Bromocriptine (Mesylate)

Overview

Categories

Primary Characterstics

Molecular Structure of Bromocriptine (Mesylate)

It is of Synthetic origin and belongs to Ergot. It belongs to D2 agonist pharmacological group on the basis of mechanism of action and also classified in Antiparkinson Agents pharmacological group.The Molecular Weight of Bromocriptine (Mesylate) is 750.80.

Its pKa is 4.9.

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Bromocriptine (Mesylate) is contraindicated in conditions like Hypertension in pregnancy, Toxaemia of pregnancy, Neurological disorders, Breast disease, Hypersensitivity to the drug.

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Bromocriptine (Mesylate)'s dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage
1.25 to 2.5 mg1.9 (1.875)12 hourlyPO

Paedriatic Dosage (20kg)
Not Recommended in this Age Group

Neonatal Dosage (3kg)
Not recommended in this age group

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Bromocriptine (Mesylate)

Back to top

Manufacturers of Bromocriptine (Mesylate) in Pakistan

Back to top

Previous Drug Generic - Next Drug Generic


Suggested Pages